|
Gene: KCNH8 |
Gene summary for KCNH8 |
Gene summary. |
Gene information | Species | Human | Gene symbol | KCNH8 | Gene ID | 131096 |
Gene name | potassium voltage-gated channel subfamily H member 8 | |
Gene Alias | ELK | |
Cytomap | 3p24.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q96L42 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
131096 | KCNH8 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.30e-02 | -9.78e-02 | 0.0155 |
131096 | KCNH8 | HTA11_1938_2000001011 | Human | Colorectum | AD | 4.50e-02 | 3.23e-01 | -0.0811 |
131096 | KCNH8 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.10e-04 | -7.85e-02 | 0.096 |
131096 | KCNH8 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.93e-08 | 1.68e+00 | 0.3487 |
131096 | KCNH8 | F007 | Human | Colorectum | FAP | 1.95e-03 | 5.35e-01 | 0.1176 |
131096 | KCNH8 | A001-C-207 | Human | Colorectum | FAP | 1.57e-05 | 5.68e-01 | 0.1278 |
131096 | KCNH8 | A015-C-203 | Human | Colorectum | FAP | 9.85e-03 | 1.82e-01 | -0.1294 |
131096 | KCNH8 | A002-C-203 | Human | Colorectum | FAP | 1.33e-08 | 6.10e-01 | 0.2786 |
131096 | KCNH8 | A001-C-119 | Human | Colorectum | FAP | 1.81e-02 | 4.72e-01 | -0.1557 |
131096 | KCNH8 | A001-C-108 | Human | Colorectum | FAP | 2.69e-08 | 5.71e-01 | -0.0272 |
131096 | KCNH8 | A002-C-021 | Human | Colorectum | FAP | 2.90e-03 | 4.06e-01 | 0.1171 |
131096 | KCNH8 | A002-C-205 | Human | Colorectum | FAP | 2.78e-05 | 4.02e-01 | -0.1236 |
131096 | KCNH8 | A001-C-104 | Human | Colorectum | FAP | 1.57e-15 | 7.04e-01 | 0.0184 |
131096 | KCNH8 | A002-C-114 | Human | Colorectum | FAP | 4.47e-04 | 4.26e-01 | -0.1561 |
131096 | KCNH8 | A015-C-104 | Human | Colorectum | FAP | 2.11e-02 | 1.82e-01 | -0.1899 |
131096 | KCNH8 | A001-C-014 | Human | Colorectum | FAP | 1.60e-05 | 4.67e-01 | 0.0135 |
131096 | KCNH8 | A001-C-203 | Human | Colorectum | FAP | 2.12e-05 | 5.18e-01 | -0.0481 |
131096 | KCNH8 | A002-C-116 | Human | Colorectum | FAP | 3.71e-02 | 2.97e-02 | -0.0452 |
131096 | KCNH8 | CRC-1-8810 | Human | Colorectum | CRC | 1.21e-03 | 4.59e-01 | 0.6257 |
131096 | KCNH8 | CRC-3-11773 | Human | Colorectum | CRC | 1.71e-07 | 4.82e-01 | 0.2564 |
Page: 1 2 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0042391 | Colorectum | CRC | regulation of membrane potential | 67/2078 | 434/18723 | 3.27e-03 | 2.81e-02 | 67 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KCNH8 | SNV | Missense_Mutation | c.1411N>T | p.Ala471Ser | p.A471S | Q96L42 | protein_coding | deleterious(0.01) | probably_damaging(0.967) | TCGA-86-7701-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | etoposide | PD | |
KCNH8 | SNV | Missense_Mutation | novel | c.59N>T | p.Thr20Ile | p.T20I | Q96L42 | protein_coding | deleterious(0.01) | possibly_damaging(0.707) | TCGA-86-8056-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
KCNH8 | SNV | Missense_Mutation | novel | c.2953N>T | p.Leu985Phe | p.L985F | Q96L42 | protein_coding | tolerated_low_confidence(0.34) | benign(0.001) | TCGA-86-8279-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | etoposide | CR |
KCNH8 | SNV | Missense_Mutation | c.580N>C | p.Val194Leu | p.V194L | Q96L42 | protein_coding | tolerated(0.84) | benign(0.042) | TCGA-86-8358-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
KCNH8 | SNV | Missense_Mutation | c.1122G>C | p.Trp374Cys | p.W374C | Q96L42 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-91-6847-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
KCNH8 | SNV | Missense_Mutation | c.2981N>T | p.Ser994Leu | p.S994L | Q96L42 | protein_coding | deleterious_low_confidence(0.01) | benign(0.251) | TCGA-93-7348-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
KCNH8 | SNV | Missense_Mutation | c.2545C>G | p.Pro849Ala | p.P849A | Q96L42 | protein_coding | tolerated(0.24) | benign(0) | TCGA-95-7039-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
KCNH8 | SNV | Missense_Mutation | c.3306C>A | p.Asn1102Lys | p.N1102K | Q96L42 | protein_coding | tolerated_low_confidence(0.18) | benign(0.01) | TCGA-95-7039-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
KCNH8 | SNV | Missense_Mutation | c.501N>A | p.Ser167Arg | p.S167R | Q96L42 | protein_coding | deleterious(0.01) | probably_damaging(0.954) | TCGA-97-8174-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | vinorelbine | SD | |
KCNH8 | SNV | Missense_Mutation | c.2672N>A | p.Val891Glu | p.V891E | Q96L42 | protein_coding | deleterious(0) | benign(0.282) | TCGA-97-A4M7-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
131096 | KCNH8 | DRUGGABLE GENOME, ION CHANNEL | blocker | CHEMBL1200728 | GUANIDINE HYDROCHLORIDE | |
131096 | KCNH8 | DRUGGABLE GENOME, ION CHANNEL | blocker | CHEMBL113461 | TEDISAMIL | |
131096 | KCNH8 | DRUGGABLE GENOME, ION CHANNEL | blocker | CHEMBL2107762 | NERISPIRDINE | |
131096 | KCNH8 | DRUGGABLE GENOME, ION CHANNEL | blocker | 135652729 | ||
131096 | KCNH8 | DRUGGABLE GENOME, ION CHANNEL | blocker | CHEMBL284348 | DALFAMPRIDINE |
Page: 1 |